HLB Co. Ltd - Asset Resilience Ratio

Latest as of March 2026: 3.29%

HLB Co. Ltd (028300) has an Asset Resilience Ratio of 3.29% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See HLB Co. Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩30.49 Billion

≈ $20.66 Million USD Cash + Short-term Investments

Total Assets

₩925.44 Billion

≈ $627.16 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2005–2025)

This chart shows how HLB Co. Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see HLB Co. Ltd total assets.

Liquid Assets Composition Over Time

This chart breaks down HLB Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 028300 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩30.49 Billion	3.29%
Total Liquid Assets	₩30.49 Billion	3.29%

Asset Resilience Insights

Limited Liquidity: HLB Co. Ltd maintains only 3.29% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

HLB Co. Ltd Industry Peers by Asset Resilience Ratio

Compare HLB Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Aurinia Pharmaceuticals Inc NASDAQ:AUPH	Biotechnology	33.23%
Nanobiotix NASDAQ:NBTX	Biotechnology	4.71%
Innovita Biological Technology Co. Ltd. A SHG:688253	Biotechnology	65.12%

Annual Asset Resilience Ratio for HLB Co. Ltd (2005–2025)

The table below shows the annual Asset Resilience Ratio data for HLB Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	5.03%	₩46.79 Billion ≈ $31.71 Million	₩930.18 Billion ≈ $630.37 Million	-10.55pp
2024-12-31	15.58%	₩138.30 Billion ≈ $93.72 Million	₩887.42 Billion ≈ $601.40 Million	+0.69pp
2023-12-31	14.89%	₩111.97 Billion ≈ $75.88 Million	₩751.72 Billion ≈ $509.43 Million	-16.65pp
2022-12-31	31.54%	₩305.09 Billion ≈ $206.75 Million	₩967.27 Billion ≈ $655.50 Million	+14.45pp
2021-12-31	17.09%	₩127.12 Billion ≈ $86.15 Million	₩743.69 Billion ≈ $503.99 Million	-14.67pp
2020-12-31	31.77%	₩224.42 Billion ≈ $152.09 Million	₩706.48 Billion ≈ $478.77 Million	+17.44pp
2019-12-31	14.33%	₩51.96 Billion ≈ $35.21 Million	₩362.61 Billion ≈ $245.74 Million	+4.12pp
2018-12-31	10.21%	₩31.03 Billion ≈ $21.03 Million	₩304.04 Billion ≈ $206.04 Million	-4.08pp
2017-12-31	14.29%	₩26.90 Billion ≈ $18.23 Million	₩188.19 Billion ≈ $127.54 Million	+4.64pp
2016-12-31	9.65%	₩18.02 Billion ≈ $12.21 Million	₩186.71 Billion ≈ $126.53 Million	+4.30pp
2015-12-31	5.35%	₩9.92 Billion ≈ $6.72 Million	₩185.17 Billion ≈ $125.49 Million	-5.11pp
2014-12-31	10.46%	₩5.68 Billion ≈ $3.85 Million	₩54.25 Billion ≈ $36.77 Million	-7.20pp
2013-12-31	17.66%	₩6.38 Billion ≈ $4.32 Million	₩36.10 Billion ≈ $24.47 Million	+12.94pp
2012-12-31	4.72%	₩1.80 Billion ≈ $1.22 Million	₩38.24 Billion ≈ $25.92 Million	-6.26pp
2011-12-31	10.98%	₩5.96 Billion ≈ $4.04 Million	₩54.25 Billion ≈ $36.76 Million	-2.29pp
2010-12-31	13.27%	₩7.71 Billion ≈ $5.23 Million	₩58.11 Billion ≈ $39.38 Million	+1.97pp
2009-12-31	11.30%	₩9.20 Billion ≈ $6.24 Million	₩81.48 Billion ≈ $55.22 Million	-4.63pp
2008-12-31	15.93%	₩11.10 Billion ≈ $7.52 Million	₩69.70 Billion ≈ $47.23 Million	+6.77pp
2007-12-31	9.16%	₩4.40 Billion ≈ $2.98 Million	₩48.05 Billion ≈ $32.56 Million	-0.73pp
2006-12-31	9.88%	₩3.19 Billion ≈ $2.16 Million	₩32.27 Billion ≈ $21.87 Million	-3.40pp
2005-12-31	13.29%	₩3.29 Billion ≈ $2.23 Million	₩24.76 Billion ≈ $16.78 Million	--

pp = percentage points

About HLB Co. Ltd

KQ:028300 Korea Biotechnology

Market Cap

$2.92 Billion

₩4.31 Trillion KRW

Market Cap Rank

#5014 Global

#113 in Korea

Share Price

₩32450.00

Change (1 day)

+6.92%

52-Week Range

₩25650.00 - ₩68200.00

All Time High

₩120800.00